Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Candu Energy Inc. is a leading Canadian nuclear technology company and a wholly owned subsidiary of AtkinsRéalis (formerly SNC-Lavalin). As the exclusive licensee and original equipment manufacturer of CANDU (Canada Deuterium Uranium) reactor technology, the company designs and delivers nuclear reactors, carries out life extension projects, and provides operations and maintenance services globally. Beyond generating clean electricity, CANDU reactors play a critical role in global healthcare as the only commercial nuclear power reactors capable of efficiently co-producing medical radioisotopes during operation. These reactors produce approximately 50% of the world's supply of Cobalt-60, used for medical equipment sterilization and cancer therapy, as well as Lutetium-177 and Molybdenum-99 for targeted cancer treatments and diagnostic imaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CANDU Energy.